✦ LIBER ✦

Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic

✍ Scribed by Emma J. Dean; Malcolm Ranson; Fiona Blackhall; Sarah V. Holt; Caroline Dive

Book ID: 116395099
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 746 KB
Volume: 33
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2006.11.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibitor of apoptosis proteins: new the

Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?

✍ de Graaf, A O; de Witte, T; Jansen, J H 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 263 KB

Targeting the Inhibitor of Apoptosis Pro

Targeting the Inhibitor of Apoptosis Proteins as a Novel Therapeutic Strategy in Medulloblastoma

✍ Keating, J.; Tsoli, M.; Hallahan, A. R.; Ingram, W. J.; Haber, M.; Ziegler, D. S 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 572 KB

The inhibitor of apoptosis protein famil

The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer

✍ Boaz Nachmias; Yaqoub Ashhab; Dina Ben-Yehuda 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Novel Polypyridyl chelators deplete cell

Novel Polypyridyl chelators deplete cellular zinc and destabilize the X-linked inhibitor of apoptosis protein (XIAP) prior to induction of apoptosis in human prostate and breast cancer cells

✍ Jian Zuo; Sara M. Schmitt; Zhen Zhang; Jai Prakash; Yuhua Fan; Caifeng Bi; Jerem 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 952 KB

210 EML4-ALK is a sensitive client prote

210 EML4-ALK is a sensitive client protein of Hsp90, and rearrangements of the ALK locus are associated with clinical response to IPI-504 (retaspimycin hydrochloride), a novel Hsp90 chaperone inhibitor, in patients with non-small cell lung cancer

✍ C. Fritz; A. Lim; K. Slocum; C. Tunkey; G. Paez; K. West; R. Ross; E. Normant; L 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB